https://orcid.org/0000-0002-8993-2693
References
- López-Muñoz F, Alamo C, Cuenca E, et al. History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry. 2005;17(3):113–135. doi:10.1080/10401230591002002.
- Hoehns JD, Stanford RH, Geraets DR, et al. Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias. Pharmacotherapy. 2001;21(7):871–883. doi:10.1592/phco.21.9.871.34565.
- Addy JA. Dopamine not effective for treatment of hypotension in chlorpromazine overdose: first case report. J Emerg Nurs. 1995;21(2):99–101. doi:10.1016/s0099-1767(05)80006-6.
- Strachan EM, Kelly CA, Bateman DN. Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning. Eur J Clin Pharmacol. 2004;60(8):541–545. doi:10.1007/s00228-004-0811-7.
- Russell SA, Hennes HM, Herson KJ, et al. Upper airway compromise in acute chlorpromazine ingestion. Am J Emerg Med. 1996;14(5):467–468. doi:10.1016/S0735-6757(96)90154-0.
- Ruiz Yanzi MA, Goicochea MT, Yorio F, et al. Intravenous chlorpromazine as potentially useful treatment for chronic headache disorders. Headache. 2020;60(10):2530–2536. doi:10.1111/head.13976.
- Edinoff AN, Armistead G, Rosa CA, et al. Phenothiazines and their evolving roles in clinical practice: a narrative review. Health Psychol Res. 2022;10(4):38930. doi:10.52965/001c.38930.
- Davis JM, Bartlett E, Termini BA. Overdosage of psychotropic drugs: a review. I. Major and minor tranquilizers. Dis Nerv Syst. 1968;29(3):157–164.
- Buckley NA, Whyte IM, Dawson AH. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol. 1995;33(3):199–204. doi:10.3109/15563659509017984.
- Leucht S, Samara M, Heres S, et al. Dose equivalents for antipsychotic drugs: theDDD method. Schizophr Bull. 2016;42 Suppl 1(Suppl 1):S90–S94. doi:10.1093/schbul/sbv167.
- Berling I, Isbister GK. Prolonged qt risk assessment in antipsychotic overdose using the QT nomogram. Ann Emerg Med. 2015;66(2):154–164.
- Berling I, Buckley NA, Isbister GK. The antipsychotic story: changes in prescriptions and overdose without better safety. Br J Clin Pharmacol. 2016;82(1):249–254. doi:10.1111/bcp.12927.
- Buckley NA, Whyte IM, Dawson AH, et al. A prospective cohort study of trends in self-poisoning, Newcastle, Australia, 1987-2012: plus ca change, plus c‘est la meme chose. Med J Aust. 2015;202(8):438–442.
- Friberg LE, Isbister GK, Hackett LP, et al. The population pharmacokinetics of citalopram after deliberate self-poisoning: a bayesian approach. J Pharmacokinet Pharmacodyn. 2005;32(3–4):571–605. doi:10.1007/s10928-005-0022-6.
- Isbister GK, Friberg LE, Hackett LP, et al. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther. 2007;81(6):821–827. doi:10.1038/sj.clpt.6100193.
- Kumar VV, Isbister GK, Duffull SB. The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose. Br J Clin Pharmacol. 2011;72(1):125–132. doi:10.1111/j.1365-2125.2011.03934.x.